Latest vaccine candidate News

Pew grant project to design hepatitis C vaccine built on natural immunity
Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
No Refrigeration Needed For Killer Disease Vaccine
Global forum takes stock of progress on new TB vaccines for adults and adolescents
Scientists Map How Body Traps ‘sleeping’ Tuberculosis
Types of data requested to inform May 2026 COVID-19 vaccine antigen composition deliberations
Global gains in tuberculosis response endangered by funding challenges
New WHO report urges bold steps for equitable access to novel TB vaccines
SAGE September 2025: key outcomes and priority actions for global immunization
Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberations
Iconic biocontainment lab marks 40 years at Australia’s disease defence frontline
New trial aims to advance research into Strep A vaccine development
Revealed: new vaccine target to block malaria transmission
New COVID-19 vaccine candidate shows strong protection against multiple variants
New platform enables rapid assembly of Nipah virus vaccine candidate
Vaccinating at every age is key to unlocking the full potential of immunization
UQ Tests Vaccine Response In ‘moonshot’ Challenge
To eradicate polio once and for all, we need a new vaccine – that’s what we’re working on
Types of data requested to inform May 2025 COVID-19 vaccine antigen composition deliberations
New data supports effective delivery of DNA-based vaccines using patch
WHO and partners enable access to candidate vaccine and treatments for outbreak of Sudan Ebola virus disease in Uganda
New EU Consortium To Tackle Marburg Virus
UQ and Vaxxas win prize to advance patch-based mRNA COVID-19 vaccine
Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
Governor of Queensland visit to Institute for Biomedicine and Glycomics highlights innovative malaria vaccine research
Volunteers needed for trial of newly developed vaccine candidate for respiratory diseases
Monash scientists uncover new, potentially longer lasting, covid vaccine targets
Types of data requested to inform December 2024 COVID-19 vaccine antigen composition deliberations
TB vaccine candidates to progress to second round of tournament
Game-changing Needle-free Covid Intranasal Vaccine
Personalised cancer vaccines to be produced at new UQ lab
New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
Personalised cancer vaccines to be produced at new UQ lab
Vaccines to treat human papillomavirus could be a significant innovation in the fight against cervical cancer
Ticking Boxes To Defeat Deadly Parasite
A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
UQ secures global partnership to create homegrown lifesaving vaccines
University of Queensland partners with Georgia’s Emory University to establish Queensland Emory Vaccine Centre
Insights from patient who cleared hepatitis C could lead to vaccine
Acquisition of Icosavax Completed
Vaccine shows promise against CMV, a virus that causes birth defects
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Successful clinical trial for re-engineered UQ vaccine
Australia, US scientists team up on African swine fever vaccine
World-first human challenge trial to test efficacy of Strep A and rheumatic heart disease vaccine
Innovative biopolymer particle-based platform technology to develop vaccine candidates
National team to advance innovative biopolymer particle-based platform technology